Trilobatin ameliorates ulcerative colitis by reducing inflammation and enhancing intestinal barrier function via regulating HMGB1-mediated TLR4/NF-κB signaling pathway

Pathology - Research and Practice 2026

View at publisher
Authors: Tao Chen, Wei Wang
DOI: 10.1016/j.prp.2026.156362
Cited by: 0
References: 32

Fields of Study & Subjects

Inflammatory Bowel Disease Natural Compounds in Disease Treatment Microscopic Colitis

Publication details

Journal / source
Pathology - Research and Practice
Volume
280
Pages
156362–156362
Publication date
13 January 2026
Language
EN